Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment

Treatment of multidrug-resistant (MDR) tuberculosis with linezolid is characterized by high rates of adverse events. Evidence on therapeutic drug monitoring to predict drug toxicity is scarce. This study aimed to evaluate the association of linezolid trough concentrations with severe toxicity. We re...

Celý popis

Podrobná bibliografie

Vydáno v:	Clinical infectious diseases Ročník 76; číslo 3; s. e947
Hlavní autoři:	Eimer, Johannes, Fréchet-Jachym, Mathilde, Le Dû, Damien, Caumes, Eric, El-Helali, Najoua, Marigot-Outtandy, Dhiba, Mechai, Frédéric, Peytavin, Gilles, Pourcher, Valérie, Rioux, Christophe, Yazdanpanah, Yazdan, Robert, Jérôme, Guglielmetti, Lorenzo
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 08.02.2023
Témata:	Antitubercular Agents - adverse effects Drug Monitoring Humans Linezolid - adverse effects Retrospective Studies Tuberculosis, Multidrug-Resistant - drug therapy toxicity severe adverse events linezolid multidrug-resistant tuberculosis therapeutic drug monitoring
ISSN:	1537-6591, 1537-6591
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!